[1] PubMed- Prostate- Serenoa repens (Permixon): a 5alpha-reductase types I and II inhibitor-new evidence in a coculture model of BPH- C W Bayne 1, F Donnelly, M Ross, F K Habib. Published Sep 1999
[2] PubMed- Acta Obstet Gynecol Scand- The effect of Permixon on androgen receptors M M el-Sheikh 1, M R Dakkak, A Saddique. Published. 1988
[3] PubMed -Cell Biol Int- Saw palmetto berry extract inhibits cell growth and Cox-2 expression in prostatic cancer cells- W H Goldmann 1, A L Sharma, S J Currier, P D Johnston, A Rana, C P Sharma. Published. 2001
[4] PubMed Cell Biol Int- Saw palmetto berry extract inhibits cell growth and Cox-2 expression in prostatic cancer cells- W H Goldmann 1, A L Sharma, S J Currier, P D Johnston, A Rana, C P Sharma. . Published 2001
[5] PubMed - J Urol- Effect of saw palmetto soft gel capsule on lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized trial in Shanghai, China -Rong Shi 1, Qiungwen Xie, X Gang, Jing Lun, Life Cheng, Allan Pantuck, Jianyu Rao. Published Feb 2008
[6] PubMed- Urology- Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia P Boyle 1, C Robertson, F Lowe, C Roehrborn. Published Apr 2000
[7] PubMed- J Altern Complement Med- A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia- Nelson Prager 1, Karen Bickett, Nita French, Geno Marcovici. Published Apr 2002
[8] PubMed World J Urol- The effect of hexanic extract of Serenoa repens on prostatic inflammation: results from a randomized biopsy study Stavros Gravas 1, Michael Samarinas 2, Konstantina Zacharouli 3, Anastasios Karatzas 2, Vasileios Tzortzis 2, Georgios Koukoulis 3, Michael Melekos 2 Published Mar 2019
_270x270.png)
(200x300)_270x270.png)
